ANI PR Wire
11 Aug 2022, 15:45 GMT+10
Ahmedabad (Gujarat) [India], August 11 (ANI/PNN): Dishman Carbogen Amcis Ltd, a fully integrated CRAMS (Contract Research and Manufacturing) company with strong capabilities right from process research and development to late-stage clinical and commercial manufacturing and supply of API to innovator pharmaceutical companies, have announced their first quarter (Q1FY23) results.
Financial performance
Consolidated Q1FY23 review
Consolidated Q1FY23 review
- Net revenue was Rs 5,406mn for Q1 FY23 as compared to Rs 5,507mn in the corresponding period of the previous year
- EBITDA stood at Rs 904 mn for Q1 FY23 as compared to Rs 1,006 mn during the corresponding period of previous year
- EBITDA Margin at 16.7 per cent for Q1 FY23 as against 18.3 per cent in Q1 FY22
- Net Profit stood at Rs 40 mn for Q1 FY23 as compared to Rs 160 mn in the corresponding period of the previous year
Q1 FY23Result Highlights
- Net Revenue at Rs 5,406 mn in Q1 FY23 down by 1.8 per cent YoY mainly on account of lower revenues from Netherlands business.
- Dishman Carbogen Amcis - NCE APIs and Intermediates revenue increased by 91.9 per cent YoY primarily due to:
- Increased supplies of APIs and intermediates from Bavla site driven by successful customer audits.
- Dishman Carbogen Amcis - Quats and Generics revenue increased by 7.1 per cent YoY primarily due to:
- Increased demand for these products especially in the exports market driven by exceptional operational performance by Naroda site.
- Carbogen Amcis - CRAMS revenue increased by 3.0 per cent YoY primarily due to:
- Higher Development revenue comprising 70 per cent of the total revenue for the quarter.
- Carbogen Amcis - Cholesterol and Vitamin D analogues revenue decreased by 46.0 per cent YoY primarily due to:
- Carbogen Amcis BV's Q1FY22 revenue was almost 38 per cent of the total year's revenue, thus extremely front-ended, which is not the case this year. One of the customers last year had stocked up huge amount of inventory in June quarter.
- EBITDA Margin at 16.3 per cent in Q1 FY23 compared to 18.3 per cent in Q1 FY22 due to:
- Higher energy costs and higher raw material costs impacted the cost base significantly in Carbogen Amcis BV in the first quarter as compared to last year same quarter.
- Higher logistics costs have also impacted the cost base globally.
- One time FX loss impact approximately Rs 9.00 crores as part of "Other Expenses"
This story is provided by PNN. ANI will not be responsible in any way for the content of this article. (ANI/PNN)
Get a daily dose of South East Asia Post news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to South East Asia Post.
More InformationBUENOS AIRES, Argentina: Since taking office in December 2023, Argentine President Javier Milei has implemented sweeping austerity...
LEMBATA, Indonesia: Indonesia's Mount Lewotobi Laki Laki erupted dramatically on June 18, generating substantial ash and smoke plumes....
MADRID, Spain: A routine oversight by Spain's power grid operator, REE, has been identified as the trigger behind the large-scale blackout...
WASHINGTON, DC - In a bid to defuse speculation, U.S. President Donald Trump says he will make his decision on whether to have the...
WASHINGTON, D.C.: A quiet shift inside the Trump administration has stalled a key diplomatic initiative aimed at pushing Russia toward...
NEW DELHI, India: Indian investigators are examining the black boxes from a Boeing 787 Dreamliner to determine the cause of a catastrophic...
NEW YORK, New YorK - U.S. stocks closed mixed on Friday, with gains and losses modest, as investors and traders weighed up the escalation...
WASHINGTON, D.C.: Retail sales dropped sharply in May as consumer spending slowed after a strong start to the year, primarily due to...
WASHINGTON, D.C.: Mitsubishi Motors is the latest automaker to raise prices in the United States, joining a growing list of car companies...
INDIANAPOLIS, Indiana: Eli Lilly is making a bold play in cardiovascular gene therapy, announcing plans to acquire its partner Verve...
BEIJING/WELLINGTON: New Zealand's Prime Minister Christopher Luxon commenced his visit to China on June 17, seeking to strengthen trade...
NEW YORK, New York - U.S. stocks made only minor moves in both directions,Thursday, as investors fretted about the Israel-Iran conflict...